BiotechTube
Home/Valneva/James (Jim) F. Cummings
J(

James (Jim) F. Cummings

General Counsel

Valneva

Roles

General CounselatValneva
EVP, U.S. Commercial & Business DevelopmentatValneva SE

Therapeutic Areas

Infectious DiseasesTravel Health

Valneva Pipeline

DrugIndicationPhase
VLA15Lyme DiseasePhase 3
IXCHIQ (VLA1553)ChikungunyaMarketed
Shigella Vaccine CandidateShigellosisPhase 2
Zika Vaccine CandidateZika VirusPhase 2

Leadership Team at Valneva

TL
Thomas Lingelbach
Chief Executive Officer
PB
Peter Bühler
Chief Financial Officer
JC
Juan Carlos Jaramillo, M.D.
Chief Medical Officer
FG
Franck Grimaud
Chief Business Officer
FJ
Frédéric Jacotot
Chief Technical Operations Officer
View full Valneva profile